Key result
Potential pharmacological alternatives and their mechanisms of action may decrease the high morbidity and mortality associated with extracorporeal membrane oxygenation weaning failure.
Answers are grounded in this paper and cite their sources.
This article calls for the implementation and investigation of new pharmacological strategies to reduce morbidity and mortality during ECMO weaning.
Extracorporeal membrane oxygenation has emerged as a viable alternative for stabilizing and improving critically ill patients in acute cardiovascular diseases. However, the weaning stage has been associated with a high morbidity and mortality rate. This makes searching for strategies that reduce failure in this final process necessary. Implementing a new approach must be tried and included in our protocols, seeking the patient’s well-being at all times. In this article, the authors discuss their point of view regarding potential pharmacological alternatives and the mechanism of action involved, which could decrease the mortality associated with this therapeutic.
No takes yet. Share an insight, caveat, or question.
González-Ruiz et al. (2023) conducted a review in Extracorporeal membrane oxygenation weaning failure. Pharmacological strategies was evaluated. Potential pharmacological alternatives and their mechanisms of action may decrease the high morbidity and mortality associated with extracorporeal membrane oxygenation weaning failure.
Synapse has enriched 10 related papers. Consider them for comparative context: